Symptoms after mould exposure including Stachybotrys chartarum, and comparison with darkroom disease

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 2, 2010, Pages 245-255

  Al Ahmad, M ^a   Manno, M ^a,b   Ng, V ^c   Ribeiro, M ^a,d,e   Liss, G M ^a,b   Tarlo, S M ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b Gage Occupational and Environmental Health Unit   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Darkroom disease; Mould; Multiple chemical sensitivity; Sick building syndrome; Stachybotrys chartarum

Indexed keywords

ADULT; ALLERGIC DISEASE; ARTICLE; ASPERGILLUS; CHEST TIGHTNESS; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DARKROOM DISEASE; DYSPNEA; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; PENICILLIUM; PRIORITY JOURNAL; QUESTIONNAIRE; SICK BUILDING SYNDROME; SKIN TEST; STACHYBOTRYS CHARTARUM;

AIR POLLUTION, INDOOR; FEMALE; FUNGI; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; SICK BUILDING SYNDROME; SKIN TESTS;

EID: 73549092730     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02157.x     Document Type: Article

References (37)

1. Dearborn DG, Infield MD, Smith P, Judge C, Horgan TE, Allan T et al. Acute pulmonary hemorrhage/hemosiderosis among infants - Cleveland, January 1993-November 1994. MMWR Morb Mortal Wkly Rep 1994 43 : 881 883.
2. Office of the Director, CDC. Update: Pulmonary hemorrhage/hemosiderosis among infants - Cleveland, Ohio, 1993-1996. MMWR Morb Mortal Wkly Rep 2000 49 : 180 184.
3. Hodgson MJ, Morey P, Leung WY, Morrow L, Miller D, Jarvis BB et al. Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J Occup Environ Med 1998 40 : 241 249.
4. Johanning E, Biagini R, Hull D, Morey P, Jarvis B, Landsbergis P. Health and immunology study following exposure to toxigenic fungi (Stachybotrys chartarum) in a water-damaged office environment. Int Arch Occup Environ Health 1996 68 : 207 218.
5. Johanning E, Landsbergis P, Gareis M, Yang CS, Olmsted E. Clinical experience and results of a sentinel health investigation related to indoor fungal exposure. Environ Health Perspect 1999 107 : 489 494.
6. Sudakin DL. Toxigenic fungi in a water-damaged building: an intervention study. Am J Ind Med 1998 34 : 183 190.
7. Poonai N, Antony MM, Binkley KE, Stenn P, Swinson RP, Corey P et al. Carbon dioxide inhalation challenges in idiopathic environmental intolerance. J Allergy Clin Immunol 2000 105 : 358 363.
8. Poonai N, Antony MM, Binkley KE, Stenn P, Swinson RP, Corey P et al. Psychological features of subjects with idiopathic environmental intolerance. J Psychosom Res 2001 51 : 537 541.
9. Tarlo SM, Liss GM, Greene JM, Purdham J, McCaskell L, Kipen H et al. Work-attributed symptom clusters (darkroom disease) among radiographers versus physiotherapists: associations between self-reported exposures and psychosocial stressors. Am J Ind Med 2004 45 : 513 521.
10. Mahmoudi M, Gershwin ME. Sick building syndrome. III. Stachybotrys chartarum. J Asthma 2000 37 : 191 198.
11. Tarlo SM, Fradkin A, Tobin RS. Skin testing with extracts of fungal species derived from the homes of allergy clinic patients in Toronto, Canada. Clin Allergy 1988 18 : 45 52.
12. Bush RK, Portnoy JM, Saxon A, Terr AI, Wood RA. The medical effects of mold exposure. J Allergy Clin Immunol 2006 117 : 326 333.
13. Portnoy JM, Kwak K, Dowling P, VanOsdol T, Barnes C. Health effects of indoor fungi. Ann Allergy Asthma Immunol 2005 94 : 313 319.
14. Crago BR, Gray M R, Nelson LA, Davis M, Arnold L, Thrasher J. Psychological, neuropsychological and electrocortical effects of indoor mold exposure. Arch Environ Health 2003 58 : 452 463.
15. Liss GM, Tarlo SM, Doherty J, Purdham J, Greene J, McCaskell L et al. Physician diagnosed asthma, respiratory symptoms, and associations with workplace tasks among radiographers in Ontario. Occup Environ Med 2003 60 : 254 261.
16. Woodcock A. Moulds and asthma: time for indoor climate change? Thorax 2007 62 : 745 746.
17. Burr ML, Matthews IP, Arthur RA, Watson HL, Gregory CJ, Dunstan FD et al. Effects on patients with asthma of eradicating visible indoor mould: a randomised controlled trial. Thorax 2007 62 : 767 772.
18. Douwes J. (1→3)-β-D-glucans and respiratory health: a review of the scientific evidence. Indoor Air 2005 15 : 160 169.
19. Gareis M, Wolff J. Relevance of mycotoxin contaminated feed for farm animals and carryover of mycotoxins to food of animal origin. Mycoses 2000 43 : 79 83.
20. Diekman MA, Green ML. Mycotoxins and reproduction in domestic livestock. J Anim Sci 1992 70 : 1615 1627.
21. Hossain MA, Ahmed MS, Ghannoum MA. Attributes of Stachybotrys chartarum and its association with human disease. J Allergy Clin Immunol 2004 113 : 200 208.
22. Pestka JJ et al. Stachybotrys chartarum, Trichothecene Mycotoxins, and damp building-related illness: new insights into a public health enigma. Toxicol Sci. 2008 104 : 4 26.
23. Van Emon JM, Reed AW, Yike I, Vesper SJ. ELISA Measurement of Stachylysin in serum to quantify human exposures to the indoor mold Stachybotrys chartarum. J Occup Environ Med 2003 45 : 582 591.
24. Iavicoli I, Brera C, Carelli G, Caputi R, Marinaccio A, Miraglia M. External and internal dose in subjects occupationally exposed to ochratoxin A. Int Arch Occup Environ Health 2002 75 : 381 386.
25. Williams JH, Phillips TD, Jolly PE, Stiles JK, Jolly CM, Aggarwal D. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am J Clin Nutr 2004 80 : 1106 1122.
26. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007 44 : 531 540.
27. Khalili B, Montanaro MT, Bardana EJ Jr. Inhalational mold toxicity: fact or fiction? A clinical review of 50 cases. Ann Allergy Asthma Immunol 2005 95 : 239 246.
28. Bardana EJ Jr. Sick building syndrome-a wolf in sheep's clothing. Ann Allergy Asthma Immunol 1997 79 : 283 293.
29. Matheson MC, Abramson MJ, Dharmage SC, Forbes AB, Raven JM, Thien FC et al. Changes in indoor allergen and fungal levels predict changes in asthma activity among young adults. Clin Exp Allergy 2005 35 : 907 913.
30. Gunnbjörnsdóttir MI, Franklin KA, Norbäck D, Björnsson E, Gislason D, Lindberg E et al. Prevalence and incidence of respiratory symptoms in relation to indoor dampness: the RHINE study. Thorax 2006 61 : 221 225.
31. Jaakkola JJ, Ieromnimon A, Jaakkola MS. Interior surface materials and asthma in adults: a population-based incident case-control study. Am J Epidemiol 2006 164 : 742 749.
32. Fisk WJ, Lei-Gomez Q, Mendell MJ. Meta-analyses of the associations of respiratory health effects with dampness and mold in homes. Indoor Air 2007 17 : 284 296.
33. Park JH, Cox-Ganser JM, Kreiss K, White SK, Rao CY. Hydrophilic fungi and ergosterol associated with respiratory illness in a water-damaged building. Environ Health Perspect 2008 116 : 45 50.
34. Kilpelainen M, Terho EO, Helenius H, Koskenvuo M. Home dampness, current allergic diseases, and respiratory infections among young adults. Thorax 2001 56 : 462 467.
35. Jaakkola JJ, Hwang BF, Jaakkola N. Home dampness and molds, parental atopy, and asthma in childhood: a six-year population-based cohort study. Environ Health Perspect 2005 113 : 357 361.
36. Pekkanen J, Hyvärinen A, Haverinen-Shaughnessy U, Korppi M, Putus T, Nevalainen A. Moisture damage and childhood asthma: a population-based incident case-control study. Eur Respir J 2007 29 : 509 515.
37. Stark PC, Burge HA, Ryan LM, Milton DK, Gold DR. Fungal levels in the home and lower respiratory tract illnesses in the first year of life. Am J Respir Crit Care Med 2003 168 : 232 237.